ANDROSTANE-3,17-DIOL, 16-(1-METHYL-1-PIPERIDINIUMYL)-2-(1-PIPERIDINYL)-, DIACETATE (ESTER), (2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-
Fibroadenoma
Xiaguang DuanSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Fibroadenoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE Xiaguang Duan | N/A | D |
SUFENTANYL Xiaguang Duan | N/A | D |
SUXAMETHONIUM Xiaguang Duan | N/A | D |
PROPOFOL Xiaguang Duan | N/A | D |
ETOMIDATE Xiaguang Duan | N/A | D |
ROPIVACAINE Xiaguang Duan | N/A | D |
Rocuronium Xiaguang Duan | N/A | D |
Same molecule, other indications
ANDROSTANE-3,17-DIOL, 16-(1-METHYL-1-PIPERIDINIUMYL)-2-(1-PIPERIDINYL)-, DIACETATE (ESTER), (2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →